相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers
Conan G. Kinsey et al.
NATURE MEDICINE (2019)
Organoids - Preclinical Models of Human Disease
Mo Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Transforming Growth Factor-β Signaling in Immunity and Cancer
Eduard Batlle et al.
IMMUNITY (2019)
Activated Fibroblast Program Orchestrates Tumor Initiation and Progression; Molecular Mechanisms and the Associated Therapeutic Strategies
Go J. Yoshida et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The WNT10B Network Is Associated with Survival and Metastases in Chemoresistant Triple-Negative Breast Cancer
Ikbale El Ayachi et al.
CANCER RESEARCH (2019)
Constructing and Deconstructing Cancers using Human Pluripotent Stem Cells and Organoids
Ryan C. Smith et al.
CELL STEM CELL (2019)
JQ1 Induces DNA Damage and Apoptosis, and Inhibits Tumor Growth in a Patient-Derived Xenograft Model of Cholangiocarcinoma
Patrick L. Garcia et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Matrix Stiffening and EGFR Cooperate to Promote the Collective Invasion of Cancer Cells
Eloise M. Grasset et al.
CANCER RESEARCH (2018)
Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer
Suk Hyung Lee et al.
CELL (2018)
A peek into cancer-associated fibroblasts: origins, functions and translational impact
Valerie S. LeBleu et al.
DISEASE MODELS & MECHANISMS (2018)
Involvement of partial EMT in cancer progression
Masao Saitoh
JOURNAL OF BIOCHEMISTRY (2018)
TNF-driven adaptive response mediates resistance to EGFR inhibition in lung cancer
Ke Gong et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine
Jia Yu et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy
Tengfei Xiao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
Georgios Vlachogiannis et al.
SCIENCE (2018)
Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy
Ali Talebi et al.
NATURE COMMUNICATIONS (2018)
Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived Xenografts
Benjamin J. Drapkin et al.
CANCER DISCOVERY (2018)
FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts
Evan F. Garner et al.
SCIENTIFIC REPORTS (2018)
High-sensitivity Detection of Micrometastases Generated by GFP Lentivirus-transduced Organoids Cultured from a Patient-derived Colon Tumor
Yu Okazawa et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2018)
Emerging roles of Myc in stem cell biology and novel tumor therapies
Go J. Yoshida
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma
Berglind O. Einarsdottir et al.
CELL DEATH & DISEASE (2018)
Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma
Olga Kondrashova et al.
NATURE COMMUNICATIONS (2018)
Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture
Shuang Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
The evolving relationship of wound healing and tumor stroma
Deshka S. Foster et al.
JCI INSIGHT (2018)
Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics
Joyce F. Liu et al.
CLINICAL CANCER RESEARCH (2017)
Targeting the ATR/CHK1 Axis with PARP Inhibition Results in Tumor Regression in BRCA-Mutant Ovarian Cancer Models
Hyoung Kim et al.
CLINICAL CANCER RESEARCH (2017)
Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment
Go J. Yoshida
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Cisplatin Increases Sensitivity to FGFR Inhibition in Patient-Derived Xenograft Models of Lung Squamous Cell Carcinoma
Clare E. Weeden et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Patient-derived xenografts undergo mouse-specific tumor evolution
Uri Ben-David et al.
NATURE GENETICS (2017)
Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts
Rita Fior et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
Chantal Pauli et al.
CANCER DISCOVERY (2017)
The anti-cancer effects of itraconazole in epithelial ovarian cancer
Chel Hun Choi et al.
SCIENTIFIC REPORTS (2017)
A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma
Clemens Krepler et al.
CELL REPORTS (2017)
Oncogenes Activate an Autonomous Transcriptional Regulatory Circuit That Drives Glioblastoma
Dinesh K. Singh et al.
CELL REPORTS (2017)
Altered metabolic landscape in IDH-mutant gliomasaffects phospholipid, energy, and oxidative stress pathways
Fred Fack et al.
EMBO MOLECULAR MEDICINE (2017)
A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors
Kurt W. Evans et al.
CLINICAL CANCER RESEARCH (2017)
Treatment of Pancreatic Cancer Patient-Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin
N. V. Rajeshkumar et al.
CLINICAL CANCER RESEARCH (2017)
A patient-derived-xenograft platform to study BRCA-deficient ovarian cancers
Erin George et al.
JCI INSIGHT (2017)
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
Gurkan Mollaoglu et al.
CANCER CELL (2017)
Antisense oligonucleotide-mediated MDM4 exon 6 skipping impairs tumor growth
Michael Dewaele et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Validation and development of MTH1 inhibitors for treatment of cancer
U. Warpman Berglund et al.
ANNALS OF ONCOLOGY (2016)
SOX2 Determines Lineage Restriction: Modeling Lung Squamous Cell Carcinoma in the Mouse
Nicole R. Murray et al.
CANCER CELL (2016)
SOX2 Is the Determining Oncogenic Switch in Promoting Lung Squamous Cell Carcinoma from Different Cells of Origin
Giustina Ferone et al.
CANCER CELL (2016)
Modeling Development and Disease with Organoids
Hans Clevers
CELL (2016)
A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis
Masayuki Fujii et al.
CELL STEM CELL (2016)
Patient-derived xenografts: a relevant preclinical model for drug development
Luca Pompili et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Dedifferentiation of Glioma Cells to Glioma Stem-like Cells By Therapeutic Stress-induced HIF Signaling in the Recurrent GBM Model
Gina Lee et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Collective invasion of cancer: Perspectives from pathology and development
Xiaoze Wang et al.
PATHOLOGY INTERNATIONAL (2016)
Inhibition of SP1 by the mithramycin analog EC-8042 efficiently targets tumor initiating cells in sarcoma
Juan Tornin et al.
ONCOTARGET (2016)
Integrated Patient-Derived Models Delineate Individualized Therapeutic Vulnerabilities of Pancreatic Cancer
Agnieszka K. Witkiewicz et al.
CELL REPORTS (2016)
Acquired resistance to immunotherapy and future challenges
Nicholas P. Restifo et al.
NATURE REVIEWS CANCER (2016)
IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer
Hongyu Zhou et al.
ACS NANO (2015)
Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin β1/FAK Signaling
Eishu Hirata et al.
CANCER CELL (2015)
Genetic Events That Limit the Efficacy of MEK and RTK Inhibitor Therapies in a Mouse Model of KRAS-Driven Pancreatic Cancer
Piergiorgio Pettazzoni et al.
CANCER RESEARCH (2015)
Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis
Giulia Bertolini et al.
CANCER RESEARCH (2015)
Evaluating Patient-Derived Colorectal Cancer Xenografts as Preclinical Models by Comparison with Patient Clinical Data
M. Nunes et al.
CANCER RESEARCH (2015)
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
Marc van de Wetering et al.
CELL (2015)
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
Sylvia F. Boj et al.
CELL (2015)
Metabolic reprogramming: the emerging concept and associated therapeutic strategies
Go J. Yoshida
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells
Devon A. Lawson et al.
NATURE (2015)
Mouse hospital and co-clinical trial project-from bench to bedside
John G. Clohessy et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases
Fleur Weeber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers
Sandra Misale et al.
NATURE COMMUNICATIONS (2015)
Snail1-Expressing Fibroblasts in the Tumor Microenvironment Display Mechanical Properties That Support Metastasis
Jelena Stanisavljevic et al.
CANCER RESEARCH (2015)
Quiescent Sox2+ Cells Drive Hierarchical Growth and Relapse in Sonic Hedgehog Subgroup Medulloblastoma
Robert J. Vanner et al.
CANCER CELL (2014)
Organoid Cultures Derived from Patients with Advanced Prostate Cancer
Dong Gao et al.
CELL (2014)
SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas
Hideo Watanabe et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts
Monique D. Topp et al.
MOLECULAR ONCOLOGY (2014)
A time-and matrix-dependent TGFBR3-JUND-KRT5 regulatory circuit in single breast epithelial cells and basal-like premalignancies
Chun-Chao Wang et al.
NATURE CELL BIOLOGY (2014)
Acquired resistance to TKIs in solid tumours: learning from lung cancer
D. Ross Camidge et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Organogenesis in a dish: Modeling development and disease using organoid technologies
Madeline A. Lancaster et al.
SCIENCE (2014)
Mutational landscape of intrahepatic cholangiocarcinoma
Shanshan Zou et al.
NATURE COMMUNICATIONS (2014)
Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
Manuel Hidalgo et al.
CANCER DISCOVERY (2014)
Influence of tumour micro-environment heterogeneity on therapeutic response
Melissa R. Junttila et al.
NATURE (2013)
Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts
Shunqiang Li et al.
CELL REPORTS (2013)
Exosomes Mediate Stromal Mobilization of Autocrine Wnt-PCP Signaling in Breast Cancer Cell Migration
Valbona Luga et al.
CELL (2012)
MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition
Dai Horiuchi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Patient-derived tumour xenografts as models for oncology drug development
John J. Tentler et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Global gene expression profiling confirms the molecular fidelity of primary tumor-based orthotopic xenograft mouse models of medulloblastoma
Xiumei Zhao et al.
NEURO-ONCOLOGY (2012)
A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma
S. Sivanand et al.
Science Translational Medicine (2012)
Molecular profiling of patient-derived breast cancer xenografts
Fabien Reyal et al.
BREAST CANCER RESEARCH (2012)
Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
Toshiro Sato et al.
GASTROENTEROLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
Yoko S. DeRose et al.
NATURE MEDICINE (2011)
High drug attrition rates-where are we going wrong?
Lisa Hutchinson et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Extracellular Matrix Degradation and Remodeling in Development and Disease
Pengfei Lu et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
A Molecularly Annotated Platform of Patient-Derived Xenografts (Xenopatients) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer
Andrea Bertotti et al.
CANCER DISCOVERY (2011)
Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth
James Kim et al.
CANCER CELL (2010)
Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis
Jerold Chun et al.
CLINICAL NEUROPHARMACOLOGY (2010)
Integrins in cancer: biological implications and therapeutic opportunities
Jay S. Desgrosellier et al.
NATURE REVIEWS CANCER (2010)
Contributions of extracellular matrix signaling and tissue architecture to nuclear mechanisms and spatial organization of gene expression control
Sophie A. Lelievre
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2009)
Cancer and the tumor microenvironment: a review of an essential relationship
Flaubert Mbeunkui et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
IL-15 trans-presentation promotes human NK cell development and differentiation in vivo
Nicholas D. Huntington et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Inhibition of CDK1 as a potential therapy for tumors over-expressing MYC
Andrei Goga et al.
NATURE MEDICINE (2007)
Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter
KE Bachman et al.
CURRENT OPINION IN ONCOLOGY (2005)
Integrin signalling during tumour progression
WJ Guo et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Interleukin-15 interactions with interleukin-15 receptor complexes: Characterization and species specificity
J Eisenman et al.
CYTOKINE (2002)